TSHA Annual Shareholders Equity
$74.94 M
+$73.99 M+7796.42%
31 December 2023
Summary:
As of January 23, 2025, TSHA annual stockholders equity is $74.94 million, with the most recent change of +$73.99 million (+7796.42%) on December 31, 2023. During the last 3 years, it has fallen by -$176.37 million (-70.18%). TSHA annual shareholders equity is now -70.18% below its all-time high of $251.30 million, reached on December 31, 2020.TSHA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TSHA Quarterly Shareholders Equity
$88.80 M
-$20.07 M-18.44%
30 September 2024
Summary:
As of January 23, 2025, TSHA quarterly stockholders equity is $88.80 million, with the most recent change of -$20.07 million (-18.44%) on September 30, 2024. Over the past year, it has increased by +$137.91 million (+280.80%). TSHA quarterly shareholders equity is now -66.82% below its all-time high of $267.64 million, reached on September 30, 2020.TSHA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TSHA Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7796.4% | +280.8% |
| 3 y3 years | -70.2% | -36.8% |
| 5 y5 years | +10000.0% | - |
TSHA Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -21.4% | +7796.4% | -18.4% | +280.8% |
| 5 y | 5-year | -70.2% | >+9999.0% | -66.8% | +280.8% |
| alltime | all time | -70.2% | >+9999.0% | -66.8% | +280.8% |
Taysha Gene Therapies Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $88.80 M(-18.4%) |
| June 2024 | - | $108.87 M(+102.2%) |
| Mar 2024 | - | $53.85 M(-28.1%) |
| Dec 2023 | $74.94 M(+7796.4%) | $74.94 M(-252.6%) |
| Sept 2023 | - | -$49.11 M(+32.3%) |
| June 2023 | - | -$37.11 M(+148.3%) |
| Mar 2023 | - | -$14.95 M(-1675.1%) |
| Dec 2022 | $949.00 K | $949.00 K(-91.5%) |
| Sept 2022 | - | $11.13 M(-66.0%) |
| June 2022 | - | $32.71 M(-35.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $50.73 M(-46.8%) |
| Dec 2021 | $95.38 M(-62.0%) | $95.38 M(-32.1%) |
| Sept 2021 | - | $140.39 M(-24.7%) |
| June 2021 | - | $186.50 M(-16.3%) |
| Mar 2021 | - | $222.87 M(-11.3%) |
| Dec 2020 | $251.30 M(<-9900.0%) | - |
| Dec 2020 | - | $251.30 M(-6.1%) |
| Sept 2020 | - | $267.64 M(-3151.1%) |
| June 2020 | - | -$8.77 M |
| Dec 2019 | -$135.00 K | - |
FAQ
- What is Taysha Gene Therapies annual stockholders equity?
- What is the all time high annual shareholders equity for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual shareholders equity year-on-year change?
- What is Taysha Gene Therapies quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly shareholders equity year-on-year change?
What is Taysha Gene Therapies annual stockholders equity?
The current annual shareholders equity of TSHA is $74.94 M
What is the all time high annual shareholders equity for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual stockholders equity is $251.30 M
What is Taysha Gene Therapies annual shareholders equity year-on-year change?
Over the past year, TSHA annual stockholders equity has changed by +$73.99 M (+7796.42%)
What is Taysha Gene Therapies quarterly stockholders equity?
The current quarterly shareholders equity of TSHA is $88.80 M
What is the all time high quarterly shareholders equity for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly stockholders equity is $267.64 M
What is Taysha Gene Therapies quarterly shareholders equity year-on-year change?
Over the past year, TSHA quarterly stockholders equity has changed by +$137.91 M (+280.80%)